Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Internship and Residency | 2 | 2025 | 746 | 1.060 |
Why?
|
| Social Media | 3 | 2025 | 117 | 0.960 |
Why?
|
| Students, Medical | 1 | 2025 | 245 | 0.770 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2018 | 140 | 0.510 |
Why?
|
| Pharmaceutical Preparations | 1 | 2017 | 117 | 0.500 |
Why?
|
| Respiratory Center | 1 | 2013 | 3 | 0.430 |
Why?
|
| Organophosphate Poisoning | 1 | 2013 | 14 | 0.430 |
Why?
|
| Respiratory Insufficiency | 1 | 2013 | 148 | 0.370 |
Why?
|
| Pneumoperitoneum | 1 | 2010 | 4 | 0.360 |
Why?
|
| Colonoscopy | 1 | 2010 | 86 | 0.340 |
Why?
|
| Faculty, Medical | 2 | 2023 | 192 | 0.320 |
Why?
|
| Drug Overdose | 2 | 2019 | 126 | 0.270 |
Why?
|
| Ethanol | 2 | 2019 | 306 | 0.250 |
Why?
|
| Poisoning | 3 | 2020 | 31 | 0.250 |
Why?
|
| Inhibin-beta Subunits | 2 | 2003 | 7 | 0.240 |
Why?
|
| Activins | 2 | 2003 | 54 | 0.230 |
Why?
|
| Plant Poisoning | 1 | 2023 | 1 | 0.220 |
Why?
|
| Androgens | 1 | 2003 | 47 | 0.220 |
Why?
|
| Foodborne Diseases | 1 | 2023 | 6 | 0.220 |
Why?
|
| Hallucinogens | 1 | 2023 | 14 | 0.220 |
Why?
|
| Cannabis | 1 | 2023 | 49 | 0.200 |
Why?
|
| Humans | 18 | 2025 | 59360 | 0.190 |
Why?
|
| Prostatic Neoplasms | 2 | 2003 | 339 | 0.190 |
Why?
|
| Toxicology | 2 | 2019 | 33 | 0.180 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 317 | 0.170 |
Why?
|
| Female | 11 | 2025 | 30705 | 0.160 |
Why?
|
| Sex Factors | 2 | 2019 | 935 | 0.160 |
Why?
|
| Testicular Hormones | 3 | 2003 | 10 | 0.160 |
Why?
|
| Male | 10 | 2025 | 27739 | 0.160 |
Why?
|
| Suicide, Attempted | 1 | 2019 | 105 | 0.150 |
Why?
|
| Efficiency | 1 | 2018 | 37 | 0.150 |
Why?
|
| Clinical Competence | 1 | 2023 | 683 | 0.150 |
Why?
|
| Writing | 1 | 2018 | 41 | 0.150 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 2373 | 0.150 |
Why?
|
| Social Support | 2 | 2018 | 355 | 0.140 |
Why?
|
| Glycoproteins | 3 | 2003 | 186 | 0.140 |
Why?
|
| Cardiovascular Agents | 1 | 2018 | 98 | 0.140 |
Why?
|
| Systems Integration | 1 | 2017 | 26 | 0.140 |
Why?
|
| Glass | 1 | 2017 | 21 | 0.140 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 2513 | 0.140 |
Why?
|
| NF-kappa B | 3 | 2004 | 460 | 0.140 |
Why?
|
| Transducers | 1 | 2017 | 26 | 0.140 |
Why?
|
| Community Networks | 1 | 2017 | 29 | 0.140 |
Why?
|
| Registries | 4 | 2023 | 801 | 0.140 |
Why?
|
| Drug Approval | 1 | 2017 | 25 | 0.130 |
Why?
|
| Morbidity | 1 | 2017 | 112 | 0.130 |
Why?
|
| Smartphone | 1 | 2017 | 64 | 0.130 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 85 | 0.130 |
Why?
|
| Weight Reduction Programs | 1 | 2017 | 55 | 0.130 |
Why?
|
| Body Weight | 1 | 2017 | 368 | 0.120 |
Why?
|
| Adult | 5 | 2025 | 15669 | 0.120 |
Why?
|
| Women's Health | 1 | 2017 | 360 | 0.110 |
Why?
|
| Research Design | 1 | 2017 | 555 | 0.110 |
Why?
|
| Diagnostic Errors | 1 | 2014 | 95 | 0.110 |
Why?
|
| Organophosphorus Compounds | 1 | 2013 | 31 | 0.110 |
Why?
|
| Retrospective Studies | 2 | 2023 | 6071 | 0.110 |
Why?
|
| Analgesics, Opioid | 1 | 2018 | 483 | 0.110 |
Why?
|
| Nerve Net | 1 | 2013 | 93 | 0.100 |
Why?
|
| Telemedicine | 1 | 2017 | 307 | 0.100 |
Why?
|
| Acute Disease | 1 | 2013 | 660 | 0.090 |
Why?
|
| Pneumonia | 1 | 2014 | 281 | 0.090 |
Why?
|
| Intestinal Perforation | 1 | 2010 | 13 | 0.090 |
Why?
|
| United States | 3 | 2019 | 7390 | 0.090 |
Why?
|
| Cell Division | 4 | 2003 | 443 | 0.080 |
Why?
|
| Immediate-Early Proteins | 3 | 2004 | 44 | 0.080 |
Why?
|
| Colon | 1 | 2010 | 136 | 0.080 |
Why?
|
| Obesity | 1 | 2017 | 1166 | 0.080 |
Why?
|
| Radiography | 1 | 2010 | 517 | 0.080 |
Why?
|
| Breast Neoplasms | 3 | 2004 | 1118 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2023 | 1782 | 0.070 |
Why?
|
| S Phase | 2 | 2003 | 74 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 450 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2004 | 194 | 0.060 |
Why?
|
| Cell Cycle | 2 | 2003 | 382 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2023 | 3067 | 0.060 |
Why?
|
| E2F Transcription Factors | 1 | 2003 | 16 | 0.060 |
Why?
|
| E2F1 Transcription Factor | 1 | 2003 | 15 | 0.060 |
Why?
|
| Smad3 Protein | 1 | 2003 | 17 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2003 | 29 | 0.060 |
Why?
|
| Retinoblastoma Protein | 1 | 2003 | 37 | 0.060 |
Why?
|
| Neoplasm Proteins | 2 | 2003 | 277 | 0.050 |
Why?
|
| Prostate-Specific Antigen | 1 | 2003 | 66 | 0.050 |
Why?
|
| Middle Aged | 4 | 2019 | 16317 | 0.050 |
Why?
|
| Psychotropic Drugs | 1 | 2023 | 81 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2003 | 2902 | 0.050 |
Why?
|
| Child | 2 | 2023 | 4174 | 0.050 |
Why?
|
| Growth Inhibitors | 1 | 2002 | 25 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 475 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2003 | 300 | 0.050 |
Why?
|
| Prostate | 1 | 2002 | 65 | 0.050 |
Why?
|
| Apoptosis | 2 | 2003 | 1032 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2003 | 551 | 0.050 |
Why?
|
| Animals | 5 | 2013 | 19651 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2003 | 884 | 0.050 |
Why?
|
| Adolescent | 2 | 2023 | 5824 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2003 | 384 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2003 | 1151 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2020 | 244 | 0.040 |
Why?
|
| Age Distribution | 1 | 2020 | 249 | 0.040 |
Why?
|
| Aged | 4 | 2019 | 13416 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2023 | 841 | 0.040 |
Why?
|
| Bites and Stings | 1 | 2018 | 11 | 0.040 |
Why?
|
| Suicidal Ideation | 1 | 2019 | 113 | 0.040 |
Why?
|
| Research Support as Topic | 1 | 2018 | 39 | 0.040 |
Why?
|
| Anti-Mullerian Hormone | 3 | 2003 | 62 | 0.040 |
Why?
|
| Polypharmacy | 1 | 2018 | 61 | 0.040 |
Why?
|
| Mentors | 1 | 2018 | 116 | 0.040 |
Why?
|
| Medication Errors | 1 | 2018 | 109 | 0.040 |
Why?
|
| Telemetry | 1 | 2017 | 19 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 2017 | 56 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 813 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 1552 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2017 | 96 | 0.030 |
Why?
|
| Forecasting | 1 | 2017 | 219 | 0.030 |
Why?
|
| Time Factors | 2 | 2020 | 3617 | 0.030 |
Why?
|
| Equipment Design | 1 | 2017 | 329 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2003 | 1471 | 0.030 |
Why?
|
| Infant | 1 | 2020 | 1486 | 0.030 |
Why?
|
| Biosensing Techniques | 1 | 2017 | 113 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 1021 | 0.030 |
Why?
|
| Mobile Applications | 1 | 2017 | 129 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2014 | 40 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2014 | 43 | 0.030 |
Why?
|
| Rhode Island | 1 | 2014 | 97 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2014 | 110 | 0.030 |
Why?
|
| Internet | 1 | 2017 | 448 | 0.030 |
Why?
|
| Mice, Inbred C3H | 2 | 2003 | 173 | 0.030 |
Why?
|
| Pregnancy | 1 | 2019 | 2202 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2003 | 146 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2014 | 255 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2003 | 689 | 0.020 |
Why?
|
| Rats | 2 | 2004 | 1910 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2014 | 416 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 4267 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2003 | 1370 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 2003 | 850 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 1526 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2004 | 70 | 0.010 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2003 | 5 | 0.010 |
Why?
|
| Activin Receptors, Type I | 1 | 2003 | 14 | 0.010 |
Why?
|
| Receptors, Growth Factor | 1 | 2003 | 19 | 0.010 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2003 | 23 | 0.010 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2003 | 29 | 0.010 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2003 | 5 | 0.010 |
Why?
|
| Receptors, Peptide | 1 | 2003 | 31 | 0.010 |
Why?
|
| Transcription Factor RelA | 1 | 2003 | 50 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2003 | 132 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 574 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 847 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2003 | 211 | 0.010 |
Why?
|
| Biopsy | 1 | 2003 | 411 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2002 | 31 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2002 | 55 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 148 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 214 | 0.010 |
Why?
|
| CHO Cells | 1 | 2002 | 189 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 366 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2002 | 365 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 584 | 0.010 |
Why?
|
| Gene Expression | 1 | 2003 | 809 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 495 | 0.010 |
Why?
|
| Mice | 2 | 2003 | 10292 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 661 | 0.010 |
Why?
|
| Models, Biological | 1 | 2002 | 1143 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2002 | 1465 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2003 | 5128 | 0.010 |
Why?
|